<p>Preoperative thinning of the endometrium:</p>

<ul>
	<li><strong>Adult:</strong>&nbsp;400-800 mg daily, in up to 4 divided doses for 3-6 week.</li>
</ul>

<p>Benign breast disorders:</p>

<ul>
	<li><strong>Adult:</strong>&nbsp;Initially, 100-400 mg daily in 2 divided doses adjusted according to response and continued for 3-6 month.</li>
</ul>

<p>Hereditary angioedema:</p>

<ul>
	<li><strong>Adult:</strong>&nbsp;Initially, 200 mg bid-tid reduced thereafter according to patient&#39;s response.</li>
</ul>

<p>Endometriosis:</p>

<ul>
	<li><strong>Adult:</strong>&nbsp;200-800 mg daily in 2 divided doses adjusted according to response, for 3-6 month or if necessary, up to 9 month.</li>
</ul>

<p>Menorrhagia:</p>

<ul>
	<li><strong>Adult:</strong>&nbsp;200 mg once daily. Review treatment 3 month later.</li>
</ul>

<p>Gynaecomastia:</p>

<ul>
	<li><strong>Adult:</strong>&nbsp;Male adolescents: Initially, 200 mg daily, may increase to 400 mg daily after 2 month if no response occurs; adult men: Initial: 400 mg daily in up to 4 divided doses. Usual treatment duration: 6 month.</li>
	<li><strong>Child:</strong>&nbsp;Male adolescents: Initially, 200 mg daily increased to 400 mg after 2 month if no response occurs. Treatment usually up to 6 months.</li>
</ul>